Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), bought 90,000 shares at $5.69 ($512K) on 2025-02-12, disclosed to the SEC on 2025-02-12.
Seasonal purchase ($512k) by President and CEO — this insider has traded ENTA in February in at least three consecutive prior years. Pattern-driven, low signal.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.69 | 45,000 | $256K | 50.0% |
| 2 | $5.69 | 45,000 | $256K | 50.0% |
| Total | $5.69 avg | 90,000 | $512K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |
| ENTA | SELL | 2022-12-16 | $2.3M | — | Filing → |